Ryan McGovern

Ryan McGovern is the Chief Financial Officer (CFO) of Adimab, a leading biotechnology company specializing in antibody discovery and engineering.12 He has been with Adimab since 2010, demonstrating a long-term commitment to the company's growth and success.2

Professional Background

Prior to joining Adimab, McGovern gained valuable experience in consulting roles. He worked as a consultant at OC&C Strategy Consultants and held a position as a senior associate at Deloitte.4 This diverse background in strategy and finance likely contributes to his effectiveness as CFO at Adimab.

Education

McGovern's educational background includes attending Dartmouth College - The Tuck School of Business at Dartmouth.3 This prestigious education has undoubtedly provided him with a strong foundation in business and finance, supporting his role as CFO.

Role at Adimab

As CFO, McGovern plays a crucial role in Adimab's financial management and strategic planning. He has been instrumental in maintaining the company's financial health, noting that "Adimab has been consistently profitable for more than a decade, a rarity in our industry".1 This achievement highlights McGovern's skill in financial stewardship and his contribution to Adimab's success in the competitive biotechnology sector.

Location and Networking

McGovern is based in Lebanon, New Hampshire, where Adimab's headquarters and research campus are located.13 He has established a strong professional network, with over 500 connections on LinkedIn3, indicating his active engagement in the industry and business community.

Ryan McGovern's LinkedIn username is ryanpatrickmcgovern, as confirmed in the query.